BUDGET IMPACT MODELLING FOR ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS IN COLOMBIA

被引：0
|
作者：
Londono, S. [1 ]
Gomez, N. [1 ]
机构：
[1] Sanofi, Bogota, Cun, Colombia
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND19
引用
收藏
页码：S625 / S625
页数：1
相关论文
共 50 条
  • [1] ALEMTUZUMAB BUDGET IMPACT ANALYSIS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE US
    Celestin, C.
    Wandstrat, T.
    Coleman, C., I
    VALUE IN HEALTH, 2015, 18 (03) : A280 - A280
  • [2] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [3] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [4] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [5] BUDGET IMPACT ANALYSIS OF ALEMTUZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN HEALTHCARE SOCIAL SECURITY (ESSALUD) IN PERU
    Moreno, M.
    Arce, J.
    Cruz, A.
    Carpio Farro, R.
    VALUE IN HEALTH, 2020, 23 : S265 - S265
  • [6] Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis
    Graves, Jennifer
    Galetta, Steven L.
    Palmer, Jeffrey
    Margolin, David H.
    Rizzo, Marco
    Bilbruck, John
    Balcer, Laura J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1302 - 1309
  • [7] The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
    Alroughani, Raed
    Van Wijmeersch, Bart
    Al Khaboori, Jabber
    Alsharoqi, Isa Ahmed
    Ahmed, Samar F.
    Hassan, Ali
    Inshasi, Jihad
    Krieger, Derk W.
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Khallaf, Mohamed
    Ezzat, Aly
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [8] Alemtuzumab Improves Contrast Sensitivity in Relapsing-Remitting Multiple Sclerosis Patients
    Balcer, Laura
    Galetta, Steven
    Maguire, Maureen
    Palmer, Jeffrey
    Margolin, David
    Rizzo, Marco
    NEUROLOGY, 2011, 76 (09) : A446 - A446
  • [9] Effect of alemtuzumab on quality of life in patients with relapsing-remitting multiple sclerosis
    Bass, Ann
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1396
  • [10] Real-life evidence of treatment with alemtuzumab in patients diagnosed with relapsing-remitting multiple sclerosis in Colombia
    Garcia Bonitto, Juan Raul
    Daniel Ayala, Oscar
    Catalina Botero, Laura
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 61
12345